BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34515012)

  • 1. Glipizide Combined with ANP Suppresses Breast Cancer Growth and Metastasis by Inhibiting Angiogenesis through VEGF/VEGFR2 Signaling.
    Mao G; Zheng S; Li J; Liu X; Zhou Q; Cao J; Zhang Q; Zheng L; Wang L; Qi C
    Anticancer Agents Med Chem; 2022; 22(9):1735-1741. PubMed ID: 34515012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.
    Qi C; Zhou Q; Li B; Yang Y; Cao L; Ye Y; Li J; Ding Y; Wang H; Wang J; He X; Zhang Q; Lan T; Lee KK; Li W; Song X; Zhou J; Yang X; Wang L
    Oncotarget; 2014 Oct; 5(20):9966-79. PubMed ID: 25294818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asiatic acid inhibits angiogenesis and vascular permeability through the VEGF/VEGFR2 signaling pathway to inhibit the growth and metastasis of breast cancer in mice.
    Tian M; Chen K; Huang J; Chu D; Li J; Huang K; Ma C
    Phytother Res; 2021 Nov; 35(11):6389-6400. PubMed ID: 34541711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis.
    Qi C; Bin Li ; Yang Y; Yang Y; Li J; Zhou Q; Wen Y; Zeng C; Zheng L; Zhang Q; Li J; He X; Zhou J; Shao C; Wang L
    Sci Rep; 2016 Jun; 6():27819. PubMed ID: 27292155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
    Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
    Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glipizide suppresses embryonic vasculogenesis and angiogenesis through targeting natriuretic peptide receptor A.
    Gu Q; Wang C; Wang G; Han Z; Li Y; Wang X; Li J; Qi C; Xu T; Yang X; Wang L
    Exp Cell Res; 2015 May; 333(2):261-272. PubMed ID: 25823921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myricetin Inhibits Breast Tumor Growth and Angiogenesis by Regulating VEGF/VEGFR2 and p38MAPK Signaling Pathways.
    Zhou Z; Mao W; Li Y; Qi C; He Y
    Anat Rec (Hoboken); 2019 Dec; 302(12):2186-2192. PubMed ID: 31266091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harmine suppresses bladder tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis.
    Hai-Rong C; Xiang H; Xiao-Rong Z
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R5, a neutralizing antibody to Robo1, suppresses breast cancer growth and metastasis by inhibiting angiogenesis via down-regulating filamin A.
    Li Q; Cao J; He Y; Liu X; Mao G; Wei B; Liao S; Zhang Q; Li J; Zheng L; Wang L; Qi C
    Exp Cell Res; 2020 Feb; 387(1):111756. PubMed ID: 31811830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway.
    Zhang Q; Lu S; Li T; Yu L; Zhang Y; Zeng H; Qian X; Bi J; Lin Y
    J Exp Clin Cancer Res; 2019 Apr; 38(1):173. PubMed ID: 31023337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways.
    Lai H; Fu X; Sang C; Hou L; Feng P; Li X; Chen T
    Chem Asian J; 2018 Jun; 13(11):1447-1457. PubMed ID: 29575811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
    Niu G; Sun L; Pei Y; Wang D
    Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer.
    Zhang J; Liu C; Shi W; Yang L; Zhang Q; Cui J; Fang Y; Li Y; Ren G; Yang S; Xiang R
    Oncotarget; 2016 Jul; 7(27):41067-41080. PubMed ID: 27203384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barbigerone, an isoflavone, inhibits tumor angiogenesis and human non-small-cell lung cancer xenografts growth through VEGFR2 signaling pathways.
    Li X; Wang X; Ye H; Peng A; Chen L
    Cancer Chemother Pharmacol; 2012 Sep; 70(3):425-37. PubMed ID: 22814678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
    Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
    Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically relevant concentrations of lidocaine inhibit tumor angiogenesis through suppressing VEGF/VEGFR2 signaling.
    Gao J; Hu H; Wang X
    Cancer Chemother Pharmacol; 2019 Jun; 83(6):1007-1015. PubMed ID: 30887179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.